PolyPeptide Group AG (SWX:PPGN)
Switzerland
· Delayed Price · Currency is CHF 20.55
+0.45 (2.24%)
Jun 26, 2025, 5:17 PM CET
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 676.43 million as of June 26, 2025. Its market cap has decreased by -36.77% in one year.
Market Cap
676.43M
Enterprise Value
710.78M
Revenue
315.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.55
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 676.43M, a decrease of -73.89%. That is a compound annual growth rate of -27.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2025 | 663.23M | -29.20% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 210.17B |
| Novartis AG | 186.95B |
| Lonza Group AG | 40.26B |
| Alcon | 34.58B |
| Galderma Group AG | 26.42B |
| Sandoz Group AG | 18.22B |
| Straumann Holding AG | 16.62B |
| Sonova Holding AG | 14.44B |